Clinical Study Results
Research Sponsor: AstraZeneca AB
Drugs Studied: Dapagliflozin
Study Title: A study to find out how dapagliflozin affects blood sugar levels in young
people with type 2 diabetes
Thank you!
Thank you for taking part in the clinical study for the study drug dapagliflozin.
You and all of the participants helped researchers learn more about dapagliflozin to help young
people with type 2 diabetes, also called T2DM.
AstraZeneca AB sponsored this study and believes it is important to share the results of the
study with you and the public. An independent non-profit organization called CISCRP helped
prepare this summary of the study results for you. We hope it helps you understand and feel
proud of your important role in medical research.
If you participated in the study and have questions about the results, please speak with the study
doctor or staff at your study site.
1